buyModerate cluster of 3
Ann L. Lee bought $113k of PRME
Chief Technical Officer at Prime Medicine, Inc.. 100,000 shares at an average of $1.13, traded May 21, 2025, filed May 22, 2025.
Conviction score
48Value
$113k
100,000 shares
Holdings after
100,000
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +10Trade size$113k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001894562-25-000028, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 21, 2025 | POpen-market purchase Common Stock | +100,000 | $1.13 | $113k | 100,000 | May 22, 2025 |
Related signals
Other insiders at Prime Medicine, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | Prime Medicine, Inc. | Gv 2021 Gp, L.l.c. owner | $5.0M 1,500,000 shares | +85% | |
| 57Moderate | Prime Medicine, Inc. | ARCH Venture Partners X, LLC owner | $10.0M 3,030,300 shares | +95% | |
| 57Moderate | Prime Medicine, Inc. | ARCH Venture Partners XII, LLC owner | $10.0M 3,030,300 shares | +95% | |
| 65Notable | Prime Medicine, Inc. | Robert Nelsen director, owner | $10.0M 3,030,300 shares | +95% | |
| 0Weak | Prime Medicine, Inc. | David R. Liu owner | $53k 21,000 shares | +0% | |
| 0Weak | Prime Medicine, Inc. | David R. Liu owner | $45k 21,000 shares | +0% | |
| 0Weak | Prime Medicine, Inc. | David R. Liu owner | $31k 21,000 shares | +0% | |
| 0Weak | Prime Medicine, Inc. | David R. Liu owner | $34k 21,000 shares | +0% | |
| 38Weak | Prime Medicine, Inc. | Richard Brudnick Chief Business Officer | $24k 20,000 shares | - | |
| 59Moderate | Prime Medicine, Inc. | Allan Reine Chief Executive Officer | $147k 125,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.